Харвестер відкритої науки НАН України

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats

von Tkalia, I.G., Vorobyova, L.I., Grabovoy, A.N., Svintsitsky, V.S., Tarasova, T.О.
Veröffentlicht in Experimental Oncology (2015)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers

von Buchynska, L.G., Iurchenko, N.P., Grinkevych, V.M., Nesina, I.P., Chekhun, S.V., Svintsitsky, V.S.
Veröffentlicht in Experimental Oncology (2009)

Clinical significance of hormonal receptor status of malignant ovarian tumors

von Tkalia, I.G., Vorobyova, L.I., Svintsitsky, V.S., Nespryadko, S.V., Goncharuk, I.V., Lukyanova, N.Y., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2014)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor

von Tkalia, I.G., Vorobyova, L.I., Grabovoy, A.N., Svintsitsky, V.S., Tarasova, T.О., Lukyanova, N.Y., Todor, I.N., Chekhun, V.F.
Veröffentlicht in Experimental Oncology (2014)